Ovarian stimulation and embryo quality

Esther B. Baart*, Nick S. Macklon, Bart J.C.M. Fauser

*Corresponding author for this work

    Research output: Contribution to journalArticleResearchpeer-review

    Abstract

    To study the effects of different ovarian stimulation approaches on oocyte and embryo quality, it is imperative to assess embryo quality with a reliable and objective method. Embryos rated as high quality by standardized morphological assessment are associated wuth higher implantation and pregnancy rates. However, embryo morphology on day 3 after fertilization is not a reliable indication of a normal chromosomal constitution. Therefore, using embryo morphology as the sole parameter for embryo quality is not ideal. Screening of embryos for chromosomal aneuploidies before tansfer can be used to assess the chromosomal competence of embryos, which has been shown to have a direct relationship with the approach used for ovarian stimulation. However, gene expression analysis of cumulus granulosa cells is a promising non-invasive technique for determining embryo quality. Cumulus cells are closely associated with oocytes, and oocyte-cumulus cell communication is vital to oocyte development. Cumulus cells respond to both gonadotrophins and paracrine factors from oocytes, with a distinct gene expression pattern. Future approaches analysing the expression of relevant genes in cumulus cells using real-time polymerase chain reaction may enable us to monitor the consenquences of different stimulation protocols and identify the underlying molecular mechanisms by which they influence oocyte/embryo quality.

    Original languageEnglish
    Pages (from-to)S45-S50
    JournalReproductive BioMedicine Online
    Volume18
    Issue numberSUPPL. 2
    DOIs
    Publication statusPublished - Apr 2009

    Funding

    The authors would like to thank Philip Li, PhD, Medicus International, for language and grammar editorial assistance with this manuscript. Editorial support was funded by Ferring Pharmaceuticals. Declaration: Esther Baart has no conflict of interest to declare. Nick Macklon and Bart Fauser have received unrestricted research grants from Ferring Pharmaceuticals, Schering-Plough and Merck Serono.

    Keywords

    • Embryo quality
    • Ovarian stimulation
    • Preimplantation genetic diagnosis

    Fingerprint

    Explore the research areas of 'Ovarian stimulation and embryo quality'.

    Cite this